The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

QuantHealth, an AI-powered clinical trial simulation company, today unveiled its Large Real-World Drug Model (LRDM v1.0), a first-of-its-kind clinical trial foundation model that can process and ...